Nuclear medicine braces for effects of Petten reactor shutdown

August 27, 2008 Nuclear medicine braces for effects of Petten reactor shutdown James Brice -------------------------------------------------------------------------------- An unscheduled shutdown of the High Flux Reactor at Petten in the Netherlands has raised concern about a possible interruption of molybdenum-99 supplies for nuclear medicine procedures in Europe and North America. The Netherlands' Nuclear Research & consultancy Group (NRG) announced Aug. 26 that isotope production from the 45-MW research reactor at Petten would be halted for at least one month because of an unplanned shutdown.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC